Educational intervention and atopic dermatitis: impact on quality of life and treatment

Educational intervention (EI) could improve understanding of atopic dermatitis (AD) and adherence to treatment, decreasing severity, and improving quality of life (QoL). This study aims to evaluate the influence of an EI on the severity of the disease and on the QoL in children with AD. A controlled...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asia Pacific allergy 2021-04, Vol.11 (2), p.e21-e21
Hauptverfasser: Muzzolon, Mariana, Imoto, Renata Robl, Canato, Mariana, Abagge, Kerstin Taniguchi, de Carvalho, Vânia Oliveira
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Educational intervention (EI) could improve understanding of atopic dermatitis (AD) and adherence to treatment, decreasing severity, and improving quality of life (QoL). This study aims to evaluate the influence of an EI on the severity of the disease and on the QoL in children with AD. A controlled clinical trial was performed, including children up to 14 years of age with AD. Patients were allocated into control group (CG), which received usual guidelines on AD during the outpatient visit, and a study group (SG) that, in addition to the usual guidelines, participated in the EI. The severity of AD was assessed by Scoring Atopic Dermatitis (SCORAD) and Eczema Area and Severity Index (EASI). QoL was assessed by the Children's Dermatology Life Quality Index and the Dermatitis Family Impact Questionnaire. Twenty-seven participants were included in the CG and 21 in the SG. There was a decrease in the median value for the QoL of children in the SG after the intervention ( = 0.04), as well as in the caregiver's ( = 0.04). In the CG, the median QoL of children and caregivers remained unaltered, for caregivers the median value for the QoL was equal throughout first and second evaluation ( = 0.32). In the SG, EASI values decreased after the intervention ( = 0.04), as well as SCORAD ( = 0.04). The CG did not show any decrease in the values of EASI ( = 0.88) scores nor of SCORAD scores ( = 0.82). The EI rendered a decrease in severity of the disease and improvement in the QoL of patients and their caregivers.
ISSN:2233-8276
2233-8268
DOI:10.5415/apallergy.2021.11.e21